nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—SLC22A5—Dactinomycin—skin cancer	0.158	1	CbGbCtD
L-Arginine—NOS3—penis—skin cancer	0.0373	0.0942	CbGeAlD
L-Arginine—Edema cerebral—Temozolomide—skin cancer	0.0323	0.103	CcSEcCtD
L-Arginine—NOS3—hindlimb—skin cancer	0.0282	0.0711	CbGeAlD
L-Arginine—NOS3—appendage—skin cancer	0.0242	0.061	CbGeAlD
L-Arginine—L-Citrulline—PADI6—skin cancer	0.023	0.598	CrCbGaD
L-Arginine—Brain oedema—Temozolomide—skin cancer	0.0175	0.056	CcSEcCtD
L-Arginine—L-Glutamine—TGM3—skin cancer	0.0155	0.402	CrCbGaD
L-Arginine—NOS3—endothelium—skin cancer	0.0146	0.0368	CbGeAlD
L-Arginine—ASS1—hair follicle—skin cancer	0.0144	0.0363	CbGeAlD
L-Arginine—Platelet count decreased—Imiquimod—skin cancer	0.014	0.0449	CcSEcCtD
L-Arginine—SLC7A4—female reproductive system—skin cancer	0.0139	0.0352	CbGeAlD
L-Arginine—ARG2—neck—skin cancer	0.0138	0.0348	CbGeAlD
L-Arginine—NOS3—blood vessel—skin cancer	0.0135	0.034	CbGeAlD
L-Arginine—ASL—female reproductive system—skin cancer	0.0124	0.0313	CbGeAlD
L-Arginine—SLC7A4—head—skin cancer	0.0116	0.0294	CbGeAlD
L-Arginine—ASL—head—skin cancer	0.0104	0.0262	CbGeAlD
L-Arginine—ASS1—nipple—skin cancer	0.00976	0.0246	CbGeAlD
L-Arginine—NOS3—neck—skin cancer	0.00962	0.0243	CbGeAlD
L-Arginine—ARG2—epithelium—skin cancer	0.00937	0.0237	CbGeAlD
L-Arginine—SLC7A1—female reproductive system—skin cancer	0.00814	0.0205	CbGeAlD
L-Arginine—ARG2—mammalian vulva—skin cancer	0.00813	0.0205	CbGeAlD
L-Arginine—Skin exfoliation—Imiquimod—skin cancer	0.00795	0.0255	CcSEcCtD
L-Arginine—AZIN2—lymph node—skin cancer	0.00781	0.0197	CbGeAlD
L-Arginine—ASL—lymph node—skin cancer	0.00726	0.0183	CbGeAlD
L-Arginine—Necrosis—Dactinomycin—skin cancer	0.00703	0.0225	CcSEcCtD
L-Arginine—SLC16A10—nipple—skin cancer	0.00697	0.0176	CbGeAlD
L-Arginine—ARG2—female reproductive system—skin cancer	0.00696	0.0176	CbGeAlD
L-Arginine—NOS3—connective tissue—skin cancer	0.0069	0.0174	CbGeAlD
L-Arginine—SLC16A10—neck—skin cancer	0.0069	0.0174	CbGeAlD
L-Arginine—Swelling—Imiquimod—skin cancer	0.00685	0.022	CcSEcCtD
L-Arginine—SLC7A1—head—skin cancer	0.0068	0.0172	CbGeAlD
L-Arginine—Extravasation—Bleomycin—skin cancer	0.00678	0.0217	CcSEcCtD
L-Arginine—ASS1—epithelium—skin cancer	0.00657	0.0166	CbGeAlD
L-Arginine—NOS3—epithelium—skin cancer	0.00655	0.0165	CbGeAlD
L-Arginine—Extravasation—Dactinomycin—skin cancer	0.00633	0.0203	CcSEcCtD
L-Arginine—ASS1—skin of body—skin cancer	0.00625	0.0158	CbGeAlD
L-Arginine—Lethargy—Imiquimod—skin cancer	0.00617	0.0198	CcSEcCtD
L-Arginine—SLC22A4—neck—skin cancer	0.00614	0.0155	CbGeAlD
L-Arginine—SLC7A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—skin cancer	0.0059	0.0619	CbGpPWpGaD
L-Arginine—Necrosis—Fluorouracil—skin cancer	0.00586	0.0188	CcSEcCtD
L-Arginine—ARG2—head—skin cancer	0.00582	0.0147	CbGeAlD
L-Arginine—ASS1—mammalian vulva—skin cancer	0.0057	0.0144	CbGeAlD
L-Arginine—Skin exfoliation—Bleomycin—skin cancer	0.00565	0.0181	CcSEcCtD
L-Arginine—Numbness—Fluorouracil—skin cancer	0.00555	0.0178	CcSEcCtD
L-Arginine—SLC7A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—skin cancer	0.00548	0.0575	CbGpPWpGaD
L-Arginine—Sensory loss—Fluorouracil—skin cancer	0.00531	0.017	CcSEcCtD
L-Arginine—Extravasation—Fluorouracil—skin cancer	0.00527	0.0169	CcSEcCtD
L-Arginine—NOS3—lymphoid tissue—skin cancer	0.00504	0.0127	CbGeAlD
L-Arginine—Decreased appetite—Vismodegib—skin cancer	0.0049	0.0157	CcSEcCtD
L-Arginine—ASS1—female reproductive system—skin cancer	0.00488	0.0123	CbGeAlD
L-Arginine—NOS3—female reproductive system—skin cancer	0.00486	0.0123	CbGeAlD
L-Arginine—Skin exfoliation—Temozolomide—skin cancer	0.00477	0.0153	CcSEcCtD
L-Arginine—SLC7A1—lymph node—skin cancer	0.00476	0.012	CbGeAlD
L-Arginine—SLC16A10—epithelium—skin cancer	0.00469	0.0118	CbGeAlD
L-Arginine—Necrosis—Docetaxel—skin cancer	0.00423	0.0136	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.00422	0.0443	CbGpPWpGaD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—PLIN2—skin cancer	0.00416	0.0436	CbGpPWpGaD
L-Arginine—SLC22A5—nipple—skin cancer	0.00411	0.0104	CbGeAlD
L-Arginine—Lethargy—Dactinomycin—skin cancer	0.00409	0.0131	CcSEcCtD
L-Arginine—ASS1—head—skin cancer	0.00408	0.0103	CbGeAlD
L-Arginine—ARG2—lymph node—skin cancer	0.00407	0.0103	CbGeAlD
L-Arginine—SLC16A10—mammalian vulva—skin cancer	0.00407	0.0103	CbGeAlD
L-Arginine—NOS3—head—skin cancer	0.00406	0.0103	CbGeAlD
L-Arginine—Flushing—Imiquimod—skin cancer	0.00388	0.0124	CcSEcCtD
L-Arginine—Extravasation—Docetaxel—skin cancer	0.0038	0.0122	CcSEcCtD
L-Arginine—Swelling—Fluorouracil—skin cancer	0.00378	0.0121	CcSEcCtD
L-Arginine—SLC16A10—lymphoid tissue—skin cancer	0.00361	0.00912	CbGeAlD
L-Arginine—Vomiting—Vismodegib—skin cancer	0.00359	0.0115	CcSEcCtD
L-Arginine—Rash—Vismodegib—skin cancer	0.00356	0.0114	CcSEcCtD
L-Arginine—Dermatitis—Vismodegib—skin cancer	0.00355	0.0114	CcSEcCtD
L-Arginine—SLC16A10—female reproductive system—skin cancer	0.00349	0.0088	CbGeAlD
L-Arginine—Anaphylactic shock—Vemurafenib—skin cancer	0.00348	0.0112	CcSEcCtD
L-Arginine—Lethargy—Fluorouracil—skin cancer	0.00341	0.0109	CcSEcCtD
L-Arginine—NOS3—VEGFR1 specific signals—RASA1—skin cancer	0.00339	0.0356	CbGpPWpGaD
L-Arginine—Nausea—Vismodegib—skin cancer	0.00335	0.0107	CcSEcCtD
L-Arginine—Injection site reaction—Docetaxel—skin cancer	0.0033	0.0106	CcSEcCtD
L-Arginine—Skin exfoliation—Docetaxel—skin cancer	0.00317	0.0102	CcSEcCtD
L-Arginine—Haematuria—Bleomycin—skin cancer	0.00316	0.0101	CcSEcCtD
L-Arginine—SLC22A4—female reproductive system—skin cancer	0.0031	0.00784	CbGeAlD
L-Arginine—Decreased appetite—Vemurafenib—skin cancer	0.00303	0.00971	CcSEcCtD
L-Arginine—Hypoaesthesia—Bleomycin—skin cancer	0.00296	0.00947	CcSEcCtD
L-Arginine—Tachycardia—Imiquimod—skin cancer	0.0029	0.00929	CcSEcCtD
L-Arginine—Hyperhidrosis—Imiquimod—skin cancer	0.00287	0.0092	CcSEcCtD
L-Arginine—ASS1—lymph node—skin cancer	0.00285	0.00721	CbGeAlD
L-Arginine—NOS3—lymph node—skin cancer	0.00285	0.00718	CbGeAlD
L-Arginine—Anorexia—Imiquimod—skin cancer	0.00283	0.00908	CcSEcCtD
L-Arginine—Flushing—Bleomycin—skin cancer	0.00276	0.00884	CcSEcCtD
L-Arginine—Swelling—Docetaxel—skin cancer	0.00273	0.00875	CcSEcCtD
L-Arginine—SLC7A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00263	0.0276	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—KRT14—skin cancer	0.00263	0.0276	CbGpPWpGaD
L-Arginine—SLC22A5—skin of body—skin cancer	0.00263	0.00664	CbGeAlD
L-Arginine—Decreased appetite—Imiquimod—skin cancer	0.00258	0.00828	CcSEcCtD
L-Arginine—Flushing—Dactinomycin—skin cancer	0.00257	0.00824	CcSEcCtD
L-Arginine—Hypersensitivity—Vemurafenib—skin cancer	0.00257	0.00823	CcSEcCtD
L-Arginine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—skin cancer	0.00252	0.0265	CbGpPWpGaD
L-Arginine—Hypoaesthesia—Temozolomide—skin cancer	0.00249	0.00799	CcSEcCtD
L-Arginine—Lethargy—Docetaxel—skin cancer	0.00246	0.00788	CcSEcCtD
L-Arginine—SLC7A3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00245	0.0257	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—MSH2—skin cancer	0.00239	0.0251	CbGpPWpGaD
L-Arginine—Flushing—Temozolomide—skin cancer	0.00233	0.00745	CcSEcCtD
L-Arginine—Hypoaesthesia—Fluorouracil—skin cancer	0.0023	0.00736	CcSEcCtD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—RASA1—skin cancer	0.00224	0.0235	CbGpPWpGaD
L-Arginine—Vomiting—Vemurafenib—skin cancer	0.00222	0.0071	CcSEcCtD
L-Arginine—Rash—Vemurafenib—skin cancer	0.0022	0.00704	CcSEcCtD
L-Arginine—NOS3—Angiopoietin receptor Tie2-mediated signaling—RASA1—skin cancer	0.0022	0.023	CbGpPWpGaD
L-Arginine—Dermatitis—Vemurafenib—skin cancer	0.0022	0.00703	CcSEcCtD
L-Arginine—Hypersensitivity—Imiquimod—skin cancer	0.00219	0.00701	CcSEcCtD
L-Arginine—Headache—Vemurafenib—skin cancer	0.00218	0.00699	CcSEcCtD
L-Arginine—Anaphylactic shock—Bleomycin—skin cancer	0.00211	0.00676	CcSEcCtD
L-Arginine—NOS2—Spinal Cord Injury—CSPG4—skin cancer	0.00211	0.0221	CbGpPWpGaD
L-Arginine—Nausea—Vemurafenib—skin cancer	0.00207	0.00663	CcSEcCtD
L-Arginine—SLC22A5—female reproductive system—skin cancer	0.00205	0.00519	CbGeAlD
L-Arginine—SLC16A10—lymph node—skin cancer	0.00204	0.00515	CbGeAlD
L-Arginine—Anorexia—Bleomycin—skin cancer	0.00201	0.00645	CcSEcCtD
L-Arginine—Vomiting—Imiquimod—skin cancer	0.00189	0.00605	CcSEcCtD
L-Arginine—Anorexia—Dactinomycin—skin cancer	0.00188	0.00601	CcSEcCtD
L-Arginine—Rash—Imiquimod—skin cancer	0.00187	0.006	CcSEcCtD
L-Arginine—Dermatitis—Imiquimod—skin cancer	0.00187	0.006	CcSEcCtD
L-Arginine—Headache—Imiquimod—skin cancer	0.00186	0.00596	CcSEcCtD
L-Arginine—NOS2—AGE/RAGE pathway—FOXO4—skin cancer	0.00186	0.0195	CbGpPWpGaD
L-Arginine—Decreased appetite—Bleomycin—skin cancer	0.00184	0.00588	CcSEcCtD
L-Arginine—SLC22A4—lymph node—skin cancer	0.00182	0.00458	CbGeAlD
L-Arginine—Anaphylactic shock—Temozolomide—skin cancer	0.00178	0.00571	CcSEcCtD
L-Arginine—Nausea—Imiquimod—skin cancer	0.00177	0.00566	CcSEcCtD
L-Arginine—Hyperhidrosis—Temozolomide—skin cancer	0.00172	0.00552	CcSEcCtD
L-Arginine—Decreased appetite—Dactinomycin—skin cancer	0.00171	0.00548	CcSEcCtD
L-Arginine—Anorexia—Temozolomide—skin cancer	0.0017	0.00544	CcSEcCtD
L-Arginine—Hypoaesthesia—Docetaxel—skin cancer	0.00166	0.00531	CcSEcCtD
L-Arginine—Anaphylactic shock—Fluorouracil—skin cancer	0.00164	0.00526	CcSEcCtD
L-Arginine—NOS2—Circadian rythm related genes—NKX2-1—skin cancer	0.00162	0.017	CbGpPWpGaD
L-Arginine—Tachycardia—Fluorouracil—skin cancer	0.0016	0.00513	CcSEcCtD
L-Arginine—Anorexia—Fluorouracil—skin cancer	0.00156	0.00501	CcSEcCtD
L-Arginine—Hypersensitivity—Bleomycin—skin cancer	0.00156	0.00498	CcSEcCtD
L-Arginine—Decreased appetite—Temozolomide—skin cancer	0.00155	0.00496	CcSEcCtD
L-Arginine—Flushing—Docetaxel—skin cancer	0.00155	0.00496	CcSEcCtD
L-Arginine—Hypersensitivity—Dactinomycin—skin cancer	0.00145	0.00465	CcSEcCtD
L-Arginine—NOS3—AGE/RAGE pathway—FOXO4—skin cancer	0.00144	0.0151	CbGpPWpGaD
L-Arginine—Decreased appetite—Fluorouracil—skin cancer	0.00143	0.00457	CcSEcCtD
L-Arginine—Vomiting—Bleomycin—skin cancer	0.00134	0.0043	CcSEcCtD
L-Arginine—SLC7A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00134	0.0141	CbGpPWpGaD
L-Arginine—Rash—Bleomycin—skin cancer	0.00133	0.00426	CcSEcCtD
L-Arginine—Dermatitis—Bleomycin—skin cancer	0.00133	0.00426	CcSEcCtD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—skin cancer	0.00132	0.0138	CbGpPWpGaD
L-Arginine—Hypersensitivity—Temozolomide—skin cancer	0.00131	0.0042	CcSEcCtD
L-Arginine—Nausea—Bleomycin—skin cancer	0.00125	0.00402	CcSEcCtD
L-Arginine—Vomiting—Dactinomycin—skin cancer	0.00125	0.00401	CcSEcCtD
L-Arginine—SLC7A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00124	0.0131	CbGpPWpGaD
L-Arginine—Rash—Dactinomycin—skin cancer	0.00124	0.00398	CcSEcCtD
L-Arginine—NOS2—HIF-1-alpha transcription factor network—TERT—skin cancer	0.00124	0.013	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—CDK4—skin cancer	0.00121	0.0127	CbGpPWpGaD
L-Arginine—Hypersensitivity—Fluorouracil—skin cancer	0.00121	0.00387	CcSEcCtD
L-Arginine—SLC22A5—lymph node—skin cancer	0.0012	0.00303	CbGeAlD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—RASA1—skin cancer	0.00119	0.0125	CbGpPWpGaD
L-Arginine—Anaphylactic shock—Docetaxel—skin cancer	0.00118	0.00379	CcSEcCtD
L-Arginine—Nausea—Dactinomycin—skin cancer	0.00117	0.00375	CcSEcCtD
L-Arginine—Tachycardia—Docetaxel—skin cancer	0.00116	0.0037	CcSEcCtD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00115	0.012	CbGpPWpGaD
L-Arginine—Vomiting—Temozolomide—skin cancer	0.00113	0.00363	CcSEcCtD
L-Arginine—Anorexia—Docetaxel—skin cancer	0.00113	0.00362	CcSEcCtD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00113	0.0118	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—RASA1—skin cancer	0.00113	0.0118	CbGpPWpGaD
L-Arginine—Rash—Temozolomide—skin cancer	0.00112	0.0036	CcSEcCtD
L-Arginine—AZIN2—Metabolism—PLIN2—skin cancer	0.00112	0.0118	CbGpPWpGaD
L-Arginine—Dermatitis—Temozolomide—skin cancer	0.00112	0.00359	CcSEcCtD
L-Arginine—Headache—Temozolomide—skin cancer	0.00112	0.00357	CcSEcCtD
L-Arginine—Nausea—Temozolomide—skin cancer	0.00106	0.00339	CcSEcCtD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—skin cancer	0.00105	0.011	CbGpPWpGaD
L-Arginine—Vomiting—Fluorouracil—skin cancer	0.00104	0.00334	CcSEcCtD
L-Arginine—Rash—Fluorouracil—skin cancer	0.00103	0.00331	CcSEcCtD
L-Arginine—Dermatitis—Fluorouracil—skin cancer	0.00103	0.00331	CcSEcCtD
L-Arginine—Decreased appetite—Docetaxel—skin cancer	0.00103	0.0033	CcSEcCtD
L-Arginine—Headache—Fluorouracil—skin cancer	0.00103	0.00329	CcSEcCtD
L-Arginine—ASL—Metabolism—PLIN2—skin cancer	0.00103	0.0108	CbGpPWpGaD
L-Arginine—Nausea—Fluorouracil—skin cancer	0.000975	0.00312	CcSEcCtD
L-Arginine—AZIN2—Metabolism—CSPG4—skin cancer	0.000905	0.00949	CbGpPWpGaD
L-Arginine—Hypersensitivity—Docetaxel—skin cancer	0.000873	0.0028	CcSEcCtD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000862	0.00905	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—RASA1—skin cancer	0.000857	0.009	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PLIN2—skin cancer	0.000851	0.00893	CbGpPWpGaD
L-Arginine—ASL—Metabolism—CSPG4—skin cancer	0.000827	0.00868	CbGpPWpGaD
L-Arginine—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	0.000785	0.00823	CbGpPWpGaD
L-Arginine—Vomiting—Docetaxel—skin cancer	0.000753	0.00241	CcSEcCtD
L-Arginine—Rash—Docetaxel—skin cancer	0.000747	0.00239	CcSEcCtD
L-Arginine—Dermatitis—Docetaxel—skin cancer	0.000746	0.00239	CcSEcCtD
L-Arginine—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—skin cancer	0.000745	0.00782	CbGpPWpGaD
L-Arginine—Headache—Docetaxel—skin cancer	0.000742	0.00238	CcSEcCtD
L-Arginine—Nausea—Docetaxel—skin cancer	0.000704	0.00225	CcSEcCtD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—FOXO4—skin cancer	0.000703	0.00738	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—NRAS—skin cancer	0.000702	0.00736	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—CDK4—skin cancer	0.000698	0.00732	CbGpPWpGaD
L-Arginine—NOS2—IL23-mediated signaling events—IL6—skin cancer	0.000687	0.00721	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—CSPG4—skin cancer	0.000686	0.0072	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ENO2—skin cancer	0.000615	0.00645	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—skin cancer	0.00061	0.0064	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—KRAS—skin cancer	0.000604	0.00634	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PLIN2—skin cancer	0.00059	0.00619	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—BRAF—skin cancer	0.000585	0.00614	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000583	0.00612	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000573	0.00602	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ENO2—skin cancer	0.000562	0.0059	CbGpPWpGaD
L-Arginine—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—skin cancer	0.000533	0.0056	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—NRAS—skin cancer	0.000532	0.00558	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—skin cancer	0.000525	0.00551	CbGpPWpGaD
L-Arginine—NOS3—Plasma membrane estrogen receptor signaling—HRAS—skin cancer	0.000513	0.00539	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—PTGS2—skin cancer	0.000499	0.00523	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CSPG4—skin cancer	0.000475	0.00499	CbGpPWpGaD
L-Arginine—NOS2—ATF-2 transcription factor network—IL6—skin cancer	0.000473	0.00496	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RHOU—skin cancer	0.000467	0.0049	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—skin cancer	0.000467	0.0049	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ENO2—skin cancer	0.000466	0.00489	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—KRAS—skin cancer	0.000458	0.0048	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—CDK4—skin cancer	0.000456	0.00478	CbGpPWpGaD
L-Arginine—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—skin cancer	0.000446	0.00468	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000438	0.0046	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—HRAS—skin cancer	0.000389	0.00408	CbGpPWpGaD
L-Arginine—NOS3—SHP2 signaling—IL6—skin cancer	0.000372	0.00391	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—BRAF—skin cancer	0.000372	0.0039	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ERCC2—skin cancer	0.000357	0.00375	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ERCC2—skin cancer	0.000327	0.00343	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—NRAS—skin cancer	0.000326	0.00342	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ENO2—skin cancer	0.000323	0.00339	CbGpPWpGaD
L-Arginine—NOS2—Disease—CSPG4—skin cancer	0.000318	0.00334	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—HRAS—skin cancer	0.000317	0.00332	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—NRAS—skin cancer	0.000307	0.00323	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—skin cancer	0.000297	0.00311	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—skin cancer	0.00028	0.00294	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—IL6—skin cancer	0.000272	0.00285	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ERCC2—skin cancer	0.000271	0.00284	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KRAS—skin cancer	0.000265	0.00278	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PLIN2—skin cancer	0.000257	0.00269	CbGpPWpGaD
L-Arginine—NOS3—Disease—CSPG4—skin cancer	0.000247	0.00259	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—skin cancer	0.000238	0.0025	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTCH2—skin cancer	0.000228	0.0024	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—IL6—skin cancer	0.000228	0.00239	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—skin cancer	0.000225	0.00236	CbGpPWpGaD
L-Arginine—NOS2—Disease—SHH—skin cancer	0.000216	0.00227	CbGpPWpGaD
L-Arginine—NOS2—Disease—ENO2—skin cancer	0.000216	0.00227	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—IL6—skin cancer	0.000215	0.00226	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—skin cancer	0.000214	0.00225	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CSPG4—skin cancer	0.000207	0.00217	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—skin cancer	0.000201	0.00211	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—skin cancer	0.000196	0.00206	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—skin cancer	0.000194	0.00203	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ERCC2—skin cancer	0.000188	0.00197	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—IL6—skin cancer	0.000177	0.00186	CbGpPWpGaD
L-Arginine—NOS2—Disease—FOXO4—skin cancer	0.000176	0.00185	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLI2—skin cancer	0.000173	0.00182	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—skin cancer	0.000171	0.00179	CbGpPWpGaD
L-Arginine—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.00017	0.00178	CbGpPWpGaD
L-Arginine—NOS3—Disease—SHH—skin cancer	0.000168	0.00176	CbGpPWpGaD
L-Arginine—NOS3—Disease—ENO2—skin cancer	0.000168	0.00176	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MC1R—skin cancer	0.000165	0.00173	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLI1—skin cancer	0.000163	0.00171	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—skin cancer	0.000162	0.0017	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SUFU—skin cancer	0.000154	0.00162	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ENO2—skin cancer	0.000141	0.00148	CbGpPWpGaD
L-Arginine—NOS3—Disease—FOXO4—skin cancer	0.000137	0.00144	CbGpPWpGaD
L-Arginine—NOS2—Disease—ERCC2—skin cancer	0.000126	0.00132	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—skin cancer	0.000121	0.00127	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—skin cancer	0.000118	0.00124	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SHH—skin cancer	0.000118	0.00123	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RASA1—skin cancer	0.000117	0.00123	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—skin cancer	0.000113	0.00118	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMO—skin cancer	0.000111	0.00117	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTCH1—skin cancer	0.000111	0.00117	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTGER4—skin cancer	0.000109	0.00114	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—skin cancer	0.000104	0.00109	CbGpPWpGaD
L-Arginine—NOS3—Disease—ERCC2—skin cancer	9.75e-05	0.00102	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FOXO4—skin cancer	9.59e-05	0.00101	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—skin cancer	9.4e-05	0.000986	CbGpPWpGaD
L-Arginine—NOS2—Disease—BRAF—skin cancer	9.32e-05	0.000978	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—skin cancer	9.26e-05	0.000972	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—skin cancer	9.14e-05	0.000959	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—skin cancer	8.86e-05	0.000929	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ERCC2—skin cancer	8.17e-05	0.000857	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—skin cancer	8.09e-05	0.000849	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—skin cancer	7.53e-05	0.00079	CbGpPWpGaD
L-Arginine—NOS3—Disease—BRAF—skin cancer	7.24e-05	0.00076	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—skin cancer	7.19e-05	0.000754	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—skin cancer	6.88e-05	0.000722	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—skin cancer	6.4e-05	0.000672	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—skin cancer	5.86e-05	0.000615	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—skin cancer	5.85e-05	0.000614	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BRAF—skin cancer	5.07e-05	0.000532	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—skin cancer	5.04e-05	0.000529	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—skin cancer	4.9e-05	0.000514	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—skin cancer	4.55e-05	0.000477	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—skin cancer	4.29e-05	0.00045	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6—skin cancer	4.1e-05	0.000431	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—skin cancer	3.92e-05	0.000411	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—skin cancer	3.33e-05	0.000349	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—skin cancer	3.19e-05	0.000334	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6—skin cancer	3.19e-05	0.000334	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—skin cancer	2.74e-05	0.000288	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—skin cancer	2.44e-05	0.000256	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—skin cancer	2.33e-05	0.000245	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6—skin cancer	2.23e-05	0.000234	CbGpPWpGaD
